| Pharmaceutical active ingredients: |
| Cinnarizine |
| Available forms, composition and doses of Denapol: |
| N / A |
| Denapol medical category: |
| Human:Antivertigo drugsPeripheral vasodilators and cerebral activators |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07CA02 - Cinnarizine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Demorphine | Dextromethorphan | Unidentified Pharmaceutical Company |
| Demosulfan | Sulfaperin | Unidentified Pharmaceutical Company |
| Demotil | Diphemanil Methylsulfate | Unidentified Pharmaceutical Company |
| Demsodrox | Dimethyl Sulfoxide | Unidentified Pharmaceutical Company |
| Demykon | Chlorphenesin | Unidentified Pharmaceutical Company |
| Denapon | Carbaryl | Unidentified Pharmaceutical Company |
| Denax | Diphenylguanidine | Unidentified Pharmaceutical Company |
| Dendritis | Sodium Chloride | Unidentified Pharmaceutical Company |
| Denkavepon | Dichlorvos | Unidentified Pharmaceutical Company |
| Denosin | Desloratadine | Unidentified Pharmaceutical Company |